253
Views
0
CrossRef citations to date
0
Altmetric
Genomics

Genetically predicted coffee consumption and amyotrophic lateral sclerosis

, & ORCID Icon
Pages 575-579 | Received 21 Dec 2021, Accepted 22 Feb 2022, Published online: 07 Mar 2022
 

Abstract

Objective: Observational studies have indicated an association between coffee consumption and amyotrophic lateral sclerosis (ALS). Nevertheless, whether the association is causal is still unclear. We conducted a Mendelian randomization study to explore whether coffee consumption is causally related to ALS. Methods: Two genome-wide association studies (GWASs) investigating coffee consumption (n = 129,422 and 375,833, respectively) were adopted to define instrumental variables for coffee consumption (high vs. infrequent/no, 1 cup/day increase, and 50% increase). Summary-level data for ALS were adopted from a large GWAS of ALS with a total of 20,806 cases and 59,804 controls. Results: Genetically predicted higher coffee consumption was not associated with ALS. The ORs were 1.02 (95% CI: 0.93–1.13; p = 0.649) for high vs. infrequent/no, 0.98 (95% CI: 0.84–1.15; p = 0.822) for 1 cup/day increase, 0.97 (95% CI: 0.79–1.19; p = 0.766) for 50% increase. Sensitivity analyses yielded consistent results. No pleiotropic bias and heterogeneity were observed. Conclusion: Using multiple approaches and sensitivity analyses, our MR results show that genetically predicted coffee consumption was not associated with ALS. Further studies are warranted to explore the effect of coffee consumption on ALS progression.

Acknowledgements

We thank the coffee and ALS GWAS Consortium for providing summary statistics data for the analyses.

Declaration of interest

None.

Data availability statement

The data used to perform the analyses were obtained from public GWASs summary statistics (see ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.